Modalis Therapeutics Corporation
[Modalis] 2026 December Term Interim Period Financial Results Briefing Materials | Including Revisions
In the second quarter of the 2026 fiscal year, cash position improved while liabilities increased, with a policy to continue R&D investments. The financial statements show changes in current assets, current liabilities, and net assets, with trends in equity ratio highlighted; capital management policy going forward is a key point.
Key Figures
- Total assets: 3,136 (million yen)
- Cash and deposits: 3,015 (million yen)
- Equity ratio: 77.2%
AI要約
Financial condition
For the second quarter of 2026, the financial condition shows asset growth with solid current assets including cash and cash equivalents, and an improving equity ratio. At the same time, the policy to continue R&D investments is explicit, with emphasis on maintaining cash position and optimizing capital efficiency. The balance sheet indicates an increase in total assets, with the movement of liabilities and net assets affecting investment decisions.
Outlook and capital policy
The policy to continue R&D investment remains; maintaining cash and deposits while determining how to manage capital policy is important. Financial soundness, cash flow stability, and improvement of ROIC are required.
Modalis
Company overview · Stock price · Financial data · All IR
